Group B streptococcus prevalence, serotype distribution and colonization dynamics in Western Australian pregnant women
Author(s) -
Lucy L. Furfaro,
Elizabeth Nathan,
Barbara J. Chang,
Matthew S. Payne
Publication year - 2019
Publication title -
journal of medical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.91
H-Index - 117
eISSN - 1473-5644
pISSN - 0022-2615
DOI - 10.1099/jmm.0.000980
Subject(s) - serotype , medicine , group b , cohort , streptococcus , meningitis , colonization , transmission (telecommunications) , streptococcus agalactiae , sepsis , pregnancy , gestation , neonatal sepsis , pediatrics , obstetrics , immunology , biology , microbiology and biotechnology , electrical engineering , bacteria , genetics , engineering
Streptococcus agalactiae, or group B streptococcus (GBS), is a leading neonatal pathogen that causes sepsis, meningitis and pneumonia. Globally, strategies have been implemented to address vertical transmission, and in Western Australia (WA), culture-based screening at 35-37 weeks' gestation is part of routine care and guides antibiotic administration. Previous Australian studies have focused on other regions or included low sample-size representatives; we aimed to describe antenatal GBS colonization in WA.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom